Associations between Plasma Cytokines and Depressive Mood in Patients with Breast Cancer

Abstract

Objective:

The few studies on the associations between cytokines and depressive mood in patients with cancer have produced conflicting results. This study investigated the associations between plasma cytokines and depressive mood in patients with breast cancer using a large panel of pro-inflammatory, anti-inflammatory, and immune-modulating cytokines.

Methods:

We recruited 273 hospitalized patients with breast cancer awaiting surgery. Preoperative plasma samples were obtained for cytokine analysis, including pro-inflammatory (interleukin [IL]-2, IL-12, interferon [IFN]-γ, and tumor necrosis factor [TNF-α]), anti-inflammatory (IL-4, IL-5, IL-10, and IL-13), and immune-modulating (granulocyte/macrophage colony-stimulating factor [GM-CSF]) cytokines. Depressive mood was measured using the Montgomery—Asberg Depression Rating Scale (MADRS) at 2–5 days postoperatively, when the patients could cooperate. Covariates included various demographic and clinical characteristics. The association between the MADRS score and each cytokine level was estimated using linear regression models.

Results:

Cytokine levels were significantly inter-correlated. Depressive mood was associated with lower levels of pro-inflammatory (IL-2, IL-12, and TNF-α), anti-inflammatory (IL-5, IL-10, and IL-13), and immune-modulating (GM-CSF) cytokines independent of potential covariates such as living area or functional level.

Conclusions:

The findings suggest that depressive mood is associated with a generally decreased inflammatory reaction or immune function in patients with breast cancer.

Keywords

depressive mood breast cancer psycho-oncology cytokine immune

Get full access to this article

View all access options for this article.

References

Hjerl

Andersen

Keiding

Mouridsen

Mortensen

Jørgensen

. Depression as a prognostic factor for breast cancer mortality. Psychosomatics 2003; 44: 24–30.

Spiegel

Giese-Davis

. Depression and cancer: Mechanisms and disease progression. Biological Psychiatry 2003; 54: 269–282.

Giese-Davis

Collie

Rancourt

Neri

Kraemer

Spiegel

. Decrease in depression symptoms is associated with longer survival in patients with metastatic breast cancer: A secondary analysis. Journal of Clinical Oncology 2011; 29: 413–420.

Seruga

Zhang

Bernstein

Tannock

. Cytokines and their relationship to the symptoms and outcome of cancer. Nature Reviews Cancer 2008; 8: 887–899.

Myers

Pierce

Pazdernik

. Neurotoxicology of chemotherapy in relation to cytokine release, the blood-brain barrier, and cognitive impairment. Oncology Nursing Forum 2008; 35: 916–920.

Maes

. Depression is an inflammatory disease, but cell-mediated immune activation is the key component of depression. Progress in Neuro-psychopharmacology and Biological Psychiatry 2010; 20. [Epub ahead of print]

Allen-Mersh

Glover

Fordy

Henderson

Davies

. Relation between depression and circulating immune products in patients with advanced colorectal cancer. Journal of the Royal Society of Medicine 1998; 91: 408–413.

Musselman

Miller

Porter

Manatunga

Gao

Penna

. Higher than normal plasma interleukin-6 concentrations in cancer patients with depression: Preliminary findings. American Journal of Psychiatry 2001; 158: 1252–1257.

Jehn

Kühnhardt

Bartholomae

Pfeiffer

Schmid

Possinger

. Association of IL-6, hypothalamus-pituitary-adrenal axis function, and depression in patients with cancer. Integrative Cancer Therapies 2010; 9: 270–275.

10.

Soygur

Palaoglu

Akarsu

Cankurtaran

Ozalp

Turhan

. Interleukin-6 levels and HPA axis activation in breast cancer patients with major depressive disorder. Progress in Neuro-psychopharmacology and Biological Psychiatry 2007; 31: 1242–1247.

11.

El-Gohary

Azzam

Ahmed

El-Shokry

. Pro-inflammatory cytokines and depression in patients with acute leukemia. The Egyptian Journal of Immunology 2008; 15: 13–24.

12.

Jacobson

Rosenfeld

Pessin

Breitbart

. Depression and IL-6 blood plasma concentrations in advanced cancer patients. Psychosomatics 2008; 49: 64–66.

13.

Sepah

Bower

. Positive affect and inflammation during radiation treatment for breast and prostate cancer. Brain, Behavior, and Immunity 2009; 23: 1068–1072.

14.

Blomberg

Alvarez

Diaz

Romero

Lechner

Carver

. Psychosocial adaptation and cellular immunity in breast cancer patients in the weeks after surgery: An exploratory study. Journal of Psychosomatic Research 2009; 67: 369–376.

15.

Von Ah

Kang

Carpenter

. Stress, optimism, and social support: Impact on immune responses in breast cancer. Research in Nursing and Health 2007; 30: 72–83.

16.

Geinitz

Zimmermann

Stoll

Thamm

Kaffenberger

Ansorg

. Fatigue, serum cytokine levels, and blood cell counts during radiotherapy of patients with breast cancer. International Journal of Radiation Oncology, Biology, Physics 2001; 51: 691–698.

17.

Mills

Parker

Dimsdale

Sadler

Ancoli-Israel

. The relationship between fatigue and quality of life and inflammation during anthracycline-based chemotherapy in breast cancer. Biological Psychology 2005; 69: 85–96.

18.

Costanzo

Lutgendorf

Sood

Anderson

Sorosky

Lubaroff

. Psychosocial factors and interleukin-6 among women with advanced ovarian cancer. Cancer 2005; 104: 305–313.

19.

Steel

Geller

Gamblin

Olek

Carr

. Depression, immunity, and survival in patients with hepatobiliary carcinoma. Journal of Clinical Oncology 2007; 25: 2397–2405.

20.

Ellman

Angeli

Christians

Moss

Chamberlain

Maguire

. Psychiatric morbidity associated with screening for breast cancer. British Journal of Cancer 1989; 60: 781–784.

21.

Akechi

Okuyama

Endo

Sagawa

Uchida

Nakaguchi

. Patient's perceived need and psychological distress and/or quality of life in ambulatory breast cancer patients in Japan. Psychooncology 2010; 11. [Epub ahead of print]

22.

Noyan

Sertoz

Elbi

Kayar

Yilmaz

. Variables affecting patient satisfaction in breast surgery: A cross-sectional sample of Turkish women with breast cancer. International Journal of Psychiatry in Medicine 2006; 36: 299–313.

23.

Kennedy

Harcourt

Rumsey

White

. The psychosocial impact of ductal carcinoma in situ (DCIS): A longitudinal prospective study. Breast 2010; 19: 382–387.

24.

Harrington

Hansen

Moskowitz

Todd

Feuerstein

. It's not over when it's over: Long-term symptoms in cancer survivors—A systematic review. International Journal of Psychiatry in Medicine 2010; 40: 163–181.

25.

Elsässer-Beile

von Kleist

Sauther

Gallati

Mönting

. Impaired cytokine production in whole blood cell cultures of patients with gynaecological carcinomas in different clinical stages. British Journal of Cancer 1993; 68: 32–36.

26.

Reiche

Morimoto

Nunes

. Stress and depression-induced immune dysfunction: Implications for the development and progression of cancer. International Review of Psychiatry 2005; 17: 515–527.

27.

Loftis

Huckans

Morasco

. Neuroimmune mechanisms of cytokine-induced depression: Current theories and novel treatment strategies. Neurobiology of Disease 2010; 37: 519–533.

28.

Schiepers

Wichers

Maes

. Cytokines and major depression. Progressive Neuropsychopharmacological Biology and Psychiatry 2005; 29: 201–217.

29.

Larson

Duberstein

Talbot

Caldwell

Moynihan

. A presurgical psychosocial intervention for breast cancer patients: Psychological distress and the immune response. Journal of Psychosomatic Research 2000; 48: 187–194.

30.

American Joint Committee on Cancer (AJCC). AJCC cancer staging handbook from the AJCC cancer staging manual (6th ed.). New York: Springer-Verlag, 2002.

31.

American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders (4th ed.). Washington, DC: American Psychiatric Press, 1994.

32.

Lee

Cho

Kwon

. Global Assessment of Functioning Scale and Social and Occupational Functioning Scale. Korean Journal of Psychopharmacology 2006; 17: 122–127.

33.

Montgomery

Asberg

. A new depression scale designed to be sensitive to change. The British Journal of Psychiatry 1979; 134: 382–389.

34.

Ahn

Lee

Kang

Kim

. A validation study of the Korean-version of the Montgomery-Asberg Depression Rating Scale. Journal of Korean Neuropsychiatric Association 2005; 44: 466–476.

35.

Dowlati

Herrmann

Swardfager

Liu

Sham

Reim

. A metaanalysis of cytokines in major depression. Biological Psychiatry 2010; 67: 446–457.

36.

Babcock

Carlin

. Transcriptional activation of indoleamine dioxygenase by interleukin 1 and tumor necrosis factor alpha in interferon-treated epithelial cells. Cytokine 2000; 12: 588–594.

37.

Stone

Behan

. Interleukin-1 beta but not tumor necrosis factor-alpha potentiates neuronal damage by quinolinic acid: Protection by anadenosine A2A receptor antagonist. Journal of Neuroscience Research 2007; 85: 1077–1085.

38.

Lutgendorf

Lamkin

DeGeest

Anderson

Dao

McGinn

. Depressed and anxious mood and T-cell cytokine expressing populations in ovarian cancer patients. Brain, Behavior, and Immunity 2008; 22: 890–900.

39.

Holtgräwe

Pinkert

Remmers

. Qualitative investigation into the strain endured by breast cancer patients in initial in-patient therapy. Pflege Zeitschrift 2008; 61: 274–277.

40.

Moynihan

. Mechanisms of stress-induced modulation of immunity. Brain, Behavior, and Immunity 2003; 17: S11–16.

41.

Dobbs

Feng

Beck

Sheridan

. Neuroendocrine regulation of cytokine production during experimental influenza viral infection: Effects of restraint stress-induced elevation in endogenous corticosterone. Journal of Immunology 1996; 157: 1870–1877.

42.

Holland

Breibart

Jacobsen

Lederberg

Loscalzo

McCorkle

. Psycho-oncology (2nd ed.). New York: Oxford University Press, 2010.

43.

Weiss

Subleski

Wigginton

Wiltrout

. Immunotherapy of cancer by IL-12-based cytokine combinations. Expert Opinion on Biological Therapy 2007; 7: 1705–1721.

44.

Kindt

Osborne

Goldsby

. Kuby immunology (6th ed.). New York: W. H. Freeman, 2006.

45.

Serve

Oelmann

Herweg

Oberberg

Serve

Reufi

. Inhibition of proliferation and clonal growth of human breast cancer cells by interleukin 13. Cancer Research 1996; 56: 3583–3588.

46.

Törer

Nursal

Calişjkan

Ezer

Colakoğlu

Moray

. The effect of the psychological status of breast cancer patients on the short-term clinical outcome after mastectomy. Acta Chirurgica Belgica 2010; 110: 467–470.

47.

Musselman

Lawson

Gumnick

Manatunga

Penna

Goodkin

. Paroxetine for the prevention of depression induced by high-dose interferon alpha. The New England Journal of Medicine 2001; 344: 961–966.

48.

Snaith

Harrop

Newby

Teale

. Grade scores of the Montgomery-Asberg Depression and the Clinical Anxiety Scales. The British Journal of Psychiatry 1986; 148: 599–601.

49.

Passik

Dugan

McDonald

Rosenfeld

Theobald

Edgerton

. Oncologists' recognition of depression in their patients with cancer. Journal of Clinical Oncology 1998; 16: 1594–1600.

50.

Fann

Thomas-Rich

Katon

Cowley

Pepping

McGregor

. Major depression after breast cancer: A review of epidemiology and treatment. General Hospital Psychiatry 2008; 30: 112–126.